$CDXC
ChromaDex Corp. Stock $cdxc

$cdxc Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000165495420011840 Filed on November 04, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q4
Revenue	$15.45M	$14.18M	$13.09M
YoY Change	18.03%	17.65%	44.32%
Cost Of Revenue	$6.020M	$5.726M	$5.620M
YoY Change	7.12%	7.96%	28.9%
Gross Profit	$9.420M	$8.454M	$7.470M
YoY Change	26.1%	25.26%	58.6%
Gross Profit Margin	60.97%	59.62%	57.07%
Selling, General & Admin	$14.51M	$11.81M	$15.19M
YoY Change	-4.48%	-6.23%	30.95%
% of Gross Profit	154.03%	139.69%	203.35%
Research & Development	$990.0K	$841.0K	$1.140M
YoY Change	-13.16%	-19.44%	-10.94%
% of Gross Profit	10.51%	9.95%	15.26%
Depreciation & Amortization	$280.0K	$280.0K	$270.0K
YoY Change	3.7%	7.69%	17.39%
% of Gross Profit	2.97%	3.31%	3.61%
Operating Expenses	$15.51M	$12.65M	$16.33M
YoY Change	-5.02%	-7.24%	26.1%
Operating Profit	-$6.090M	-$4.196M	-$8.860M
YoY Change	-31.26%	-39.08%	7.52%
Interest Expense	-$20.00K	$19.00K	$10.00K
YoY Change	-300.0%	-93.95%	-50.0%
% of Operating Profit
Other Income/Expense, Net		-$19.00K	$0.00
YoY Change		-93.95%
Pretax Income	-$6.100M	-$4.220M	-$8.850M
YoY Change	-31.07%	-41.39%	7.66%
Income Tax
% Of Pretax Income
Net Earnings	-$6.100M	-$4.215M	-$8.850M
YoY Change	-31.07%	-41.47%	7.66%
Net Earnings / Revenue	-39.48%	-29.72%	-67.61%
Basic Earnings Per Share		-$0.07
Diluted Earnings Per Share	-$98.58K	-$0.07	-$148.3K
COMMON SHARES
Basic Shares Outstanding	61.79M shares	61.70M shares
Diluted Shares Outstanding		61.70M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.70M	$15.48M	$18.81M
YoY Change	-11.22%	-18.01%	-16.84%
Cash & Equivalents	$16.70M	$15.48M	$18.81M
Short-Term Investments
Other Short-Term Assets	$1.150M	$1.010M	$1.000M
YoY Change	15.0%	-5.61%	72.41%
Inventory	$11.68M	$11.03M	$11.54M
Prepaid Expenses
Receivables	$2.694M	$2.210M	$1.380M
Other Receivables	$900.0K	$1.000M	$800.0K
Total Short-Term Assets	$32.22M	$30.73M	$33.52M
YoY Change	-3.88%	-15.51%	-8.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.206M	$3.307M	$3.765M
YoY Change	-14.85%	-30.23%	4.87%
Goodwill
YoY Change
Intangibles	$1.082M	$1.147M	$1.311M
YoY Change	-17.47%
Long-Term Investments
YoY Change
Other Assets	$625.0K	$910.0K	$762.0K
YoY Change	-17.98%	37.88%	33.68%
Total Long-Term Assets	$6.139M	$6.687M	$6.729M
YoY Change	-8.77%	-1.23%	18.05%
TOTAL ASSETS
Total Short-Term Assets	$32.22M	$30.73M	$33.52M
Total Long-Term Assets	$6.139M	$6.687M	$6.729M
Total Assets	$38.36M	$37.42M	$40.25M
YoY Change	-4.69%	-13.27%	-4.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.445M	$6.881M	$9.626M
YoY Change	-1.88%	11.52%	0.8%
Accrued Expenses	$6.133M	$5.173M	$4.415M
YoY Change	38.91%	20.02%	2.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$30.00K	$80.00K	$260.0K
YoY Change	-88.46%	-71.43%	52.94%
Total Short-Term Liabilities	$16.48M	$13.02M	$15.06M
YoY Change	9.38%	18.1%	4.31%
LONG-TERM LIABILITIES
Long-Term Debt	$20.00K	$20.00K	$20.00K
YoY Change	0.0%	-71.43%	-85.71%
Other Long-Term Liabilities	$5.440M	$4.890M	$4.720M
YoY Change	15.25%	-0.2%	883.33%
Total Long-Term Liabilities	$5.460M	$4.910M	$4.740M
YoY Change	15.19%	-1.21%	664.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.48M	$13.02M	$15.06M
Total Long-Term Liabilities	$5.460M	$4.910M	$4.740M
Total Liabilities	$21.93M	$17.93M	$19.80M
YoY Change	10.77%	12.05%	31.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$141.8M	-$135.7M	-$121.9M
YoY Change	16.35%
Common Stock	$62.00K	$62.00K	$60.00K
YoY Change	3.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.42M	$19.49M	$20.45M
YoY Change
Total Liabilities & Shareholders Equity	$38.36M	$37.42M	$40.25M
YoY Change	-4.69%	-13.27%	-4.7%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q4
OPERATING ACTIVITIES
Net Income	-$6.100M	-$4.215M	-$8.850M
YoY Change	-31.07%	-41.47%	7.66%
Depreciation, Depletion And Amortization	$280.0K	$280.0K	$270.0K
YoY Change	3.7%	7.69%	17.39%
Cash From Operating Activities	$20.00K	-$3.840M	-$610.0K
YoY Change	-103.28%	-50.52%	-88.13%
INVESTING ACTIVITIES
Capital Expenditures	$30.00K	-$60.00K	-$280.0K
YoY Change	-110.71%	-60.0%	211.11%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$550.0K
YoY Change	-100.0%		-271.88%
Cash From Investing Activities	$10.00K	-$60.00K	$270.0K
YoY Change	-96.3%	-60.0%	-164.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.180M	490.0K	270.0K
YoY Change	337.04%	-93.03%	-775.0%
NET CHANGE
Cash From Operating Activities	20.00K	-3.840M	-610.0K
Cash From Investing Activities	10.00K	-60.00K	270.0K
Cash From Financing Activities	1.180M	490.0K	270.0K
Net Change In Cash	1.210M	-3.410M	-70.00K
YoY Change	-1828.57%	287.5%	-98.75%
FREE CASH FLOW
Cash From Operating Activities	$20.00K	-$3.840M	-$610.0K
Capital Expenditures	$30.00K	-$60.00K	-$280.0K
Free Cash Flow	-$10.00K	-$3.780M	-$330.0K
YoY Change	-96.97%	-50.33%	-93.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18000	USD
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61787728	shares
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	200000	USD
CY2020Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	3214000	USD
CY2019Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2175000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	33518000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	19802000	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61587000	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	62000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	155156000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15063000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18812000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	11535000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	996000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3765000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1311000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	891000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	762000	USD
CY2019Q4	us-gaap	Assets Assets	40247000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9626000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4415000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	595000	USD
CY2020Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	83000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	258000	USD
CY2019Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	169000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13015000	USD
CY2020Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3820000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	200000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15478000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	2800000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	0.0	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1005000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	30728000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3307000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1147000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1323000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	910000	USD
CY2020Q3	us-gaap	Assets Assets	37415000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6881000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5173000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	650000	USD
CY2020Q3	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	228000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1000000.0	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	800000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	11031000	USD
CY2019Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3873000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	848000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1070000	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	23000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	17928000	USD
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59562000	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	60000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	142285000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121900000	USD
CY2019Q4	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax	0	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	20445000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40247000	USD
CY2020Q3	us-gaap	Revenues Revenues	14180000	USD
CY2019Q3	us-gaap	Revenues Revenues	12053000	USD
	us-gaap	Revenues Revenues	43812000	USD
	us-gaap	Revenues Revenues	33202000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	5726000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	5304000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135728000	USD
CY2020Q3	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax	-3000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	19487000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37415000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	17959000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	14898000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	8454000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	6749000	USD
	us-gaap	Gross Profit GrossProfit	25853000	USD
	us-gaap	Gross Profit GrossProfit	18304000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5223000	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4626000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14629000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13108000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	880000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1044000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2741000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3281000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6547000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7967000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22256000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24230000	USD
CY2020Q3	us-gaap	Other Expenses OtherExpenses	0	USD
CY2019Q3	us-gaap	Other Expenses OtherExpenses	0	USD
	us-gaap	Other Expenses OtherExpenses	0	USD
	us-gaap	Other Expenses OtherExpenses	125000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	12650000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	13637000	USD
	us-gaap	Operating Expenses OperatingExpenses	39626000	USD
	us-gaap	Operating Expenses OperatingExpenses	40744000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4196000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6888000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13773000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22440000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	19000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	314000	USD
	us-gaap	Interest Expense InterestExpense	55000	USD
	us-gaap	Interest Expense InterestExpense	854000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-314000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-55000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-854000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4215000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-7202000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13828000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-23294000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	61695000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57658000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60797000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56182000	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	21581000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1686000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-7202000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4215000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	19487000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10622000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19829000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	147000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	463000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	18000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	15145000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6773000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	547000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1574000	USD
CY2019Q3	cdxc	Issuanceofcommonstock Forconversionofdebtandaccruedinterest Amount IssuanceofcommonstockForconversionofdebtandaccruedinterestAmount	10123000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	282000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	335000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	565000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2859000	USD
CY2019Q3	cdxc	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3873000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	56000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-14000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-181000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-521000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4856000	USD
	cdxc	Increase Decrease In Principal Payments On Operating Leases IncreaseDecreaseInPrincipalPaymentsOnOperatingLeases	-440000	USD
	cdxc	Increase Decrease In Principal Payments On Operating Leases IncreaseDecreaseInPrincipalPaymentsOnOperatingLeases	-488000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6773000	USD
	cdxc	Proceeds From Sale Of Convertible Notes ProceedsFromSaleOfConvertibleNotes	0	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	27142000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	20445000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4856000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2859000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5158000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-3000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13828000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	19487000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	27178000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6773000	USD
	cdxc	Issuanceofcommonstock Forconversionofdebtandaccruedinterestvalue IssuanceofcommonstockForconversionofdebtandaccruedinterestvalue	10123000	USD
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	282000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	606000	USD
	cdxc	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5474000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-23294000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	27142000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13828000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-23294000	USD
	us-gaap	Depreciation Depreciation	652000	USD
	us-gaap	Depreciation Depreciation	559000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	182000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	184000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	284000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	423000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5158000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5474000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2737000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	846000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	75000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	123000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1698000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1590000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	504000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1570000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-185000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-353000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2745000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3379000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	757000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-619000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-53000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	16000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	48000	USD
	cdxc	Proceeds From Sale Of Convertible Notes ProceedsFromSaleOfConvertibleNotes	10000000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	30000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	606000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57658000	shares
CY2020Q3	us-gaap	Cash Cash	15500000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	200000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60797000	shares
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	216000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	201000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7469000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16613000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3334000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3737000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	200000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18812000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22616000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	200000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15478000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18879000	USD
	us-gaap	Interest Paid Net InterestPaidNet	11000	USD
	us-gaap	Interest Paid Net InterestPaidNet	26000	USD
	cdxc	Financing Lease Obligation Incurred For Prepayment Of Licensing Fees FinancingLeaseObligationIncurredForPrepaymentOfLicensingFees	0	USD
	cdxc	Financing Lease Obligation Incurred For Prepayment Of Licensing Fees FinancingLeaseObligationIncurredForPrepaymentOfLicensingFees	99000	USD
	cdxc	Operating Lease Obligation Incurred For Entering Into Lease Amendment OperatingLeaseObligationIncurredForEnteringIntoLeaseAmendment	716000	USD
	cdxc	Operating Lease Obligation Incurred For Entering Into Lease Amendment OperatingLeaseObligationIncurredForEnteringIntoLeaseAmendment	0	USD
	cdxc	Financing Lease Obligation Incurred For Purchase Of Computer Equipment And Software FinancingLeaseObligationIncurredForPurchaseOfComputerEquipmentAndSoftware	47000	USD
	cdxc	Financing Lease Obligation Incurred For Purchase Of Computer Equipment And Software FinancingLeaseObligationIncurredForPurchaseOfComputerEquipmentAndSoftware	143000	USD
	cdxc	Operating Lease Obligation Incurred For Tenant Improvement Credit Received OperatingLeaseObligationIncurredForTenantImprovementCreditReceived	0	USD
	cdxc	Operating Lease Obligation Incurred For Tenant Improvement Credit Received OperatingLeaseObligationIncurredForTenantImprovementCreditReceived	64000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	10123000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:left;"><strong>Note 2.<span style="font:7pt times new roman"> </span>Nature of Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ChromaDex is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of nicotinamide adenine dinucleotide and its impact on human health. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive intellectual property protection. The Company also has analytical reference standards and services segment, which focuses on natural product fine chemicals (known as “phytochemicals”) and related chemistry services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p>
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	61695000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4215000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-7202000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13828000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-23294000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2020Q3	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	The lease amendment extends the expiration of the lease period from February 2024 to December 2025.
CY2020Q3	cdxc	Amount Of Additional Lease Payable During Lease Term AmountOfAdditionalLeasePayableDuringLeaseTerm	900000	USD
CY2020Q3	cdxc	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	1300000	USD
CY2020Q3	cdxc	Operating Lease Liabilities OperatingLeaseLiabilities	1700000	USD
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	120000	USD
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	180000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	359000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56182000	shares
CY2020Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2500000	USD
CY2019Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2300000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	7200000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	5500000	USD
CY2020Q3	us-gaap	Other Receivables OtherReceivables	1000000.0	USD
CY2019Q4	us-gaap	Other Receivables OtherReceivables	800000	USD
CY2020Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7242000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4877000	USD
CY2020Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1971000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4659000	USD
CY2020Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1194000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1364000	USD
CY2020Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	624000	USD
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	635000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	11031000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	11535000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	540000	USD
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	5000	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	61000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	139000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	182000	USD
CY2020Q3	cdxc	Total Operating Lease Expense TotalOperatingLeaseExpense	125000	USD
CY2019Q3	cdxc	Total Operating Lease Expense TotalOperatingLeaseExpense	241000	USD
	cdxc	Total Operating Lease Expense TotalOperatingLeaseExpense	498000	USD
	cdxc	Total Operating Lease Expense TotalOperatingLeaseExpense	722000	USD
CY2020Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	63000	USD
CY2019Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	191000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000	USD
CY2020Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	188000	USD
CY2019Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	245000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	689000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	729000	USD
	cdxc	Weighted Average Remaining Lease Term Years Operating Leases WeightedAverageRemainingLeaseTermYearsOperatingLeases	P2Y8M12D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.72	pure
CY2020Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	175000	USD
CY2020Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	622000	USD
CY2020Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	289000	USD
CY2020Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	289000	USD
CY2020Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	306000	USD
CY2020Q3	us-gaap	Operating Leases Future Minimum Payments Due In Rolling Year Two OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo	316000	USD
CY2020Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1996000	USD
CY2020Q3	cdxc	Operating Leases Future Minimum Payments Present Value Of Net Minimum Payments OperatingLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	276000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1720000	USD
CY2020Q3	cdxc	Operating Lease Liability Less Current Portion OperatingLeaseLiabilityLessCurrentPortion	650000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1070000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	400000	USD
CY2020Q3	cdxc	Finance Lease Liabilities FinanceLeaseLiabilities	100000	USD
CY2020Q3	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	22000	USD
CY2019Q3	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	19000	USD
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	83000	USD
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	56000	USD
CY2020Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000	USD
CY2019Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	8000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	11000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	26000	USD
CY2020Q3	cdxc	Finance Leases Rent Expense Net FinanceLeasesRentExpenseNet	24000	USD
CY2019Q3	cdxc	Finance Leases Rent Expense Net FinanceLeasesRentExpenseNet	27000	USD
	cdxc	Finance Leases Rent Expense Net FinanceLeasesRentExpenseNet	94000	USD
	cdxc	Finance Leases Rent Expense Net FinanceLeasesRentExpenseNet	82000	USD
	cdxc	Weighted Average Remaining Lease Term Years Finance Leases WeightedAverageRemainingLeaseTermYearsFinanceLeases	P1Y1M6D
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.77	pure
CY2020Q3	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	58000	USD
CY2020Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	32000	USD
CY2020Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	21000	USD
CY2020Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	111000	USD
CY2020Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	5000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	106000	USD
CY2020Q3	cdxc	Finance Lease Liability Less Current Portion FinanceLeaseLiabilityLessCurrentPortion	83	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	23000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	As of September 30, 2020, under the 2017 Plan, the Company is authorized to issue shares subject to awards that total no more than the sum of (i) 14,500,000 new shares, (ii) approximately 384,000 unallocated shares remaining available for the grant of new awards under the 2007 Plan, (iii) any returning shares from the 2007 Plan or the 2017 Plan, such as forfeited, cancelled, or expired shares and (iv) 500,000 shares pursuant to an inducement award. The remaining number of shares available for issuance under the 2017 Plan totaled approximately 6.7 million shares at September 30, 2020.
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	66	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	1	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Other Expenses OtherExpenses	125000	USD
CY2020Q3	cdxc	Net Sales NetSales	14180000	USD
	us-gaap	Operating Expenses OperatingExpenses	40744000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22440000	USD
CY2020Q3	us-gaap	Share Price SharePrice	4.01
CY2020Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7800000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1574000	USD
CY2019Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1686000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5158000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5474000	USD
	us-gaap	Revenues Revenues	43812000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	17959000	USD
	us-gaap	Gross Profit GrossProfit	25853000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14629000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2741000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22256000	USD
	us-gaap	Operating Expenses OperatingExpenses	39626000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13773000	USD
	us-gaap	Revenues Revenues	33202000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	14898000	USD
	us-gaap	Gross Profit GrossProfit	18304000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13108000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3281000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24230000	USD
	cdxc	Schedule Of Inventory Purchase Obligations ScheduleOfInventoryPurchaseObligations	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="margin:0px 0px 0px 0in">Three Months Ending December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.7Million</td><td style="width:1%;white-space: nowrap;"><p style="margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="margin:0px 0px 0px 0in">Twelve Months Ending December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">14.6 Million</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>18.3 Million</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="margin:0px"> </p></td></tr></tbody></table><p style="margin:0px"/>
CY2020Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	3700000	USD
CY2020Q3	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	14600000	USD
CY2020Q3	us-gaap	Purchase Obligation PurchaseObligation	18300000	USD

Files In Submission

Name	View Source	Status
0001654954-20-011840-index-headers.html	Edgar Link	pending
0001654954-20-011840-index.html	Edgar Link	pending
0001654954-20-011840.txt	Edgar Link	pending
0001654954-20-011840-xbrl.zip	Edgar Link	pending
cdcx_10q.htm	Edgar Link	pending
cdcx_10q_htm.xml	Edgar Link	completed
cdcx_ex101.htm	Edgar Link	pending
cdcx_ex102.htm	Edgar Link	pending
cdcx_ex103.htm	Edgar Link	pending
cdcx_ex104.htm	Edgar Link	pending
cdcx_ex105.htm	Edgar Link	pending
cdcx_ex106.htm	Edgar Link	pending
cdcx_ex107.htm	Edgar Link	pending
cdcx_ex108.htm	Edgar Link	pending
cdcx_ex108img2.jpg	Edgar Link	pending
cdcx_ex311.htm	Edgar Link	pending
cdcx_ex312.htm	Edgar Link	pending
cdcx_ex321.htm	Edgar Link	pending
cdxc-20200930.xsd	Edgar Link	pending
cdxc-20200930_cal.xml	Edgar Link	unprocessable
cdxc-20200930_def.xml	Edgar Link	unprocessable
cdxc-20200930_lab.xml	Edgar Link	unprocessable
cdxc-20200930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDXC
ChromaDex Corp. Stock $cdxc

2020 Q4 Form 10-Q Financial Statement

#000165495420011840 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDXC ChromaDex Corp. Stock $cdxc

2020 Q4 Form 10-Q Financial Statement

#000165495420011840 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDXC
ChromaDex Corp. Stock $cdxc